Tissue Inhibitors of Metalloproteinases 1 Confers 5-Fluorouracil Resistance and Stemness of Gastric Cancer Cells via the Up-Regulation of Hypoxia-Inducible Factor-1α

The role and potential mechanism of TIMP1 in resistance to 5-Fluorouracil (5-Fu) and stem properties in gastric cancer (GC) were investigated. The expressions of HIF-1α and TIMP1, as well as the chemosensitivity of the 5-Fu in GC cell lines (GCCL) (e.g., MGC-803, BGC-823, SGC-7901, HGC-27 and AGS) upon normoxia or hypoxia were analyzed by means of RT-PCR and CCK-8 assay, respectively. Meanwhile, the population of stem cells was determined by using sphere formation assay, while stem cell markers (SCM) (Oct4 and CD44) were detected by western blot to evaluate stem properties. Hypoxia led to upregulated expression of HIF-1α and TIMP1, and enhanced resistance to 5-Fu, sphere formation capability, and expression of SCM in GC cells (GCCs). Indeed, the expressions of TIMP1 and HIF-1α were positively related to each other. The protein levels of both HIF-1α and TIMP1 were increased and decreased by overexpressing and silencing TIMP1, respectively. Under hypoxia conditions, overexpression of TIMP1 conferred 5-Fu-resistance and stem properties to MGC-803 and AGS cells, as revealed by increased IC50 value of 5-Fu, enhanced sphere formation, and up-regulation of Oct4 and CD44; silencing TIMP1 caused the contrary results. TIMP1 is an effective regulator of HIF-1 and plays a critical role in resistance to 5-Fu and stem properties in GCCs upon hypoxia.

[1]  Hao Wang,et al.  HIF1α/VEGF Feedback Loop Contributes to 5-Fluorouracil Resistance , 2022, Frontiers in Pharmacology.

[2]  W. Zhang,et al.  ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer , 2022, Journal of Experimental & Clinical Cancer Research.

[3]  Sheng-Xiong Zhang,et al.  Current Advances and Outlook in Gastric Cancer Chemoresistance: A Review. , 2021, Recent patents on anti-cancer drug discovery.

[4]  R. Salehi,et al.  The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment , 2021, Cancer Cell International.

[5]  M. Donadelli,et al.  Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons , 2021, Journal of experimental & clinical cancer research : CR.

[6]  R. Perona,et al.  Targeting MAD2 modulates stemness and tumorigenesis in human Gastric Cancer cell lines , 2020, Theranostics.

[7]  M. Xie,et al.  Role of hypoxia in cancer therapy by regulating the tumor microenvironment , 2019, Molecular Cancer.

[8]  Xin Liang,et al.  Hypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1α/miR-338-5p/IL-6 Feedback Loop. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  A. Rojiani,et al.  TIMP-1-Mediated Chemoresistance via Induction of IL-6 in NSCLC , 2019, Cancers.

[10]  D. Y. Hwang,et al.  Inhibition of skin carcinogenesis by suppression of NF-κB dependent ITGAV and TIMP-1 expression in IL-32γ overexpressed condition , 2018, Journal of experimental & clinical cancer research : CR.

[11]  Andrew N Lane,et al.  Collagen prolyl 4-hydroxylase 1 is essential for HIF-1α stabilization and TNBC chemoresistance , 2018, Nature Communications.

[12]  Yuehua Wu,et al.  Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer , 2018, World journal of gastroenterology.

[13]  P. Pauwels,et al.  Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress , 2018, Cancers.

[14]  Angela L. Riffo-Campos,et al.  Emerging Role of miRNAs in the Drug Resistance of Gastric Cancer , 2016, International journal of molecular sciences.

[15]  J. Marin,et al.  Mechanisms of Resistance to Chemotherapy in Gastric Cancer. , 2016, Anti-cancer agents in medicinal chemistry.

[16]  Dorte B. Bekker-Jensen,et al.  TIMP-1 increases expression and phosphorylation of proteins associated with drug resistance in breast cancer cells. , 2013, Journal of proteome research.

[17]  N. Brünner,et al.  Tissue inhibitor of metalloproteinase 1 (TIMP-1) as a biomarker in gastric cancer: a review , 2013, Scandinavian journal of gastroenterology.

[18]  T. Cramer,et al.  Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways. , 2011, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[19]  Yongmin Yan,et al.  Oct4, a novel marker for human gastric cancer , 2009, Journal of surgical oncology.

[20]  T. Wang,et al.  Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44 , 2009, Stem cells.

[21]  D. Ito,et al.  Hypoxia induces resistance to 5-fluorouracil in oral cancer cells via G(1) phase cell cycle arrest. , 2009, Oral oncology.

[22]  E. Sasaki,et al.  Synergistic antitumor effect of combined 5-fluorouracil (5-FU) with 5-chloro-2,4-dihydroxypyridine on 5-FU-resistant gastric cancer cells: possible role of a dihydropyrimidine dehydrogenase-independent mechanism , 2007, Journal of Gastroenterology.

[23]  E. Fredlund,et al.  Hypoxia-induced dedifferentiation of tumor cells--a mechanism behind heterogeneity and aggressiveness of solid tumors. , 2005, Seminars in cell & developmental biology.

[24]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[25]  J. Norman,et al.  Hypoxia promotes fibrogenesis in human renal fibroblasts. , 2000, Kidney international.